Provenance Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Provenance Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	2,619 +5	+0.2%	+$659	0.03%	102
2026 Q1	$364K	Hold	2,614	–	–	0.04%	86
2025 Q4	$321K	Hold	2,614	–	–	0.04%	86
2025 Q3	$290K	Hold	2,614	–	–	0.04%	96
2025 Q2	$290K	Sell	2,614 -25	-0.9%	-$2.66K	0.04%	93
2025 Q1	$296K	Sell	2,639 -1,559	-37%	-$161K	0.04%	103
2024 Q4	$388K	Sell	4,198 -12,372	-75%	-$1.11M	0.05%	104
2024 Q3	$1.39M	Buy	16,570 +426	+3%	+$32.5K	0.17%	50
2024 Q2	$1.11M	Buy	16,144 +472	+3%	+$31.5K	0.15%	55
2024 Q1	$1.15M	Buy	15,672 +445	+3%	+$34.2K	0.16%	53
2023 Q4	$1.23M	Buy	15,227 +220	+1%	+$17.1K	0.17%	43
2023 Q3	$1.12M	Buy	+15,007	New	+$1.15M	0.18%	41

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Provenance Wealth Advisors's GILD Position: Q2 2026 in Review

Provenance Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.19% in Q2 2026, buying an estimated $659 and bringing the position to 2,619 shares worth $331K. The position accounts for 0.03% of the portfolio, ranked #102.

Provenance Wealth Advisors first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Provenance Wealth Advisors held 2,619 shares of Gilead Sciences worth $331K as of Q2 2026.
Provenance Wealth Advisors bought 5 Gilead Sciences shares in Q2 2026, an estimated $659.
Gilead Sciences made up 0.03% of Provenance Wealth Advisors's portfolio in Q2 2026, its #102 holding.
Provenance Wealth Advisors first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
Provenance Wealth Advisors's Gilead Sciences position peaked at $1.39M in Q3 2024.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.